Vanguard reports zero CLMT holdings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed an amendment to Schedule 13G/A reporting 0 shares of Calumet Inc. The amendment notes an internal realignment on January 12, 2026 and explains that certain subsidiaries/business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The filing is signed on 03/26/2026 and shows no sole or shared voting or dispositive power over Calumet common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Vanguard change how it reports its Calumet Inc holdings (CLMT)?
When was the Schedule 13G/A amendment for CLMT signed and filed?
Who signed the CLMT Schedule 13G/A amendment for Vanguard?
Does the filing identify any third party with rights to dividends or sale proceeds for CLMT?
AI-generated analysis. How Rhea-AI works. Not financial advice.